Association of angiotensin II type 2 receptor gene A1818T polymorphism with progression of immunoglobulin a nephropathy in Korean patients

Journal of Korean Medical Science

Volumn 24, Issue SUPPL.1, 2009, Pages

  Yoon, Hyung Jin ^a   Chin, Ho Jun ^b,c   Na, Ki Young ^b   Chae, Dong Wan ^b,c   Kim, Suhnggwon ^a,c   Jeon, Un Sil ^d   Chung, Woo Kyung ^e   Lee, Hyun Hee ^e   Yang, Jaeseok ^e   Kim, Sejoong ^e   Kwon, Young Joo ^f   Kim, Hyun Chul ^g   Park, Sung Bae ^g   Kim, Hye Young ^h   Lee, Tae Woo ^a,c   Jang, Eun Hee ⁱ   Kim, Won ^j   Kim, Nam Ho ^k   Bae, Woo Kyun ^k   Shin, Young Tai ^l   Lee, Kang Wook ^l   Na, Ki Ryang ^l   Ahn, Ki Sung ^m   Cho, Jong Tae ⁿ   Lee, Eun Kyeong ⁿ   Kim, Ki Hyun ^o   An, Wonsuk ^o   Kim, Seong Eun ^o   Bog, Choi Gyu ^p   Kim, Seung Jung ^p   Chang, Se Ho ^q   Noh, Jung Woo ^r   Lee, Young Ki ^r   Kim, Seong Gyun ^r   Oh, Jieun ^r   Song, Young Rim ^r   Kim, Moon Jae ^s   Lee, Seoung Woo ^s   Kim, Yeong Hoon ^t   Park, Won Do ^t   Kim, Kyo Soon ^u   Cho, Won Yong ^v   Kim, Hyung Kyu ^v   Jo, Sang Kyung ^v   Ryong, Cha Dae ^w   Sun, Kang Young ^w   Kim, Yong Lim ^x   Park, Sun Hee ^x   Kim, Chan Duck ^x   Yang, Dong Ho ^y   Kwak, Ihm Soo ^z   Lee, Soo Bong ^z   Lee, Dong Won ^z   Song, Sang Heon ^z   Seoung, Eun Young ^z   Yoon, Su Jin ^aa   Lim, Chun Soo ^ab   Oh, Yoon Kyu ^ab   Oh, Kook Hwan ^a   Joo, Kwon Wook ^a   Kim, Yon Su ^a   Ahn, Curie ^a   Han, Jin Suk ^a   Lee, Kyu Beck ^ac   Kim, Yoon Goo ^ac   Lee, Jung Eun ^ac   Lee, Sang Koo ^ad   Do, Jun Young ^ae   Park, Jong Won ^ae   Yoon, Kyung Woo ^ae   more..

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d Pohang University of Science and Technology (POSTECH)   (South Korea)

^e Gachon University   (South Korea)

^f Korea University College of Medicine   (South Korea)

^g Keimyung University School of Medicine   (South Korea)

^h Chungbuk National University College of Medicine   (South Korea)

ⁱ Jeju National University College of Medicine   (South Korea)

^j Chonbuk National University Medical School   (South Korea)

^k Chonnam National University Medical School   (South Korea)

^l Chungnam National University College of Medicine   (South Korea)

^m Catholic University of Daegu   (South Korea)

ⁿ Dankook University   (South Korea)

^o Dong A University College of Medicine   (South Korea)

^p Ewha Womans University School of Medicine   (South Korea)

^q Gyeongsang National University   (South Korea)

^r Hallym University College of Medicine   (South Korea)

^s Inha University School of Medicine   (South Korea)

^t Inje University College of Medicine   (South Korea)

^u Konkuk University School of Medicine   (South Korea)

^v College of Medicine   (South Korea)

^w Korea University   (South Korea)

^x Kyungpook National University School of Medicine   (South Korea)

^y CHA University   (South Korea)

^z Pusan National University School of Medicine   (South Korea)

^aa Seoul Medical Center   (South Korea)

^ab Seoul National University College of Medicine   (South Korea)

^ac Sungkyunkwan University School of Medicine   (South Korea)

^ad University of Ulsan College of Medicine   (South Korea)

^ae Yeungnam University College of Medicine   (South Korea)

more..

Author keywords

Angiotensin; Glomerulonephritis; IGA; Polymorphism; Receptor; Single nucleotide; Type 2

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; CREATININE;

ALLELE; ARTICLE; BIOLOGICAL MODEL; BLOOD; DISEASE COURSE; ETHNOLOGY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KOREA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; TIME; TREATMENT OUTCOME;

ALLELES; CREATININE; DISEASE PROGRESSION; GENOTYPE; GLOMERULONEPHRITIS, IGA; HUMANS; KOREA; MODELS, GENETIC; MODELS, STATISTICAL; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ANGIOTENSIN, TYPE 2; TIME FACTORS; TREATMENT OUTCOME;

EID: 62449129906     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.S1.S38     Document Type: Article

References (24)

1. Yagame M, Suzuki D, Jinde K, Saotome N, Murakami R, Asakura K, Nakashima R, Kashem A, Yano N, Endoh M, Nomoto Y, Sakai H, Tomino Y. Value of pathological grading in prediction of renal survival in IgA nephropathy. Nephrology 1996; 2: 107-17.
2. Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis 1997; 29: 526-32.
3. Li PK, Ho KK, Szeto CC, Yu L, Lai FM. Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspec tives. Nephrol Dial Transplant 2002; 17: 64-9.
4. Frimat L, Briançon S, Hestin D, Aymard B, Renoult E, Huu TC, Kessler M. IgA nephropathy: prognostic classification of end-stage renal failure. Nephrol Dial Transplant 1997; 12: 2569-75.
5. Rychlik I, Andrassy K, Waldherr R, Zuna I, Tesar V, Jancova E, Stejskalova A, Ritz E. Clinical features and natural history of IgA nephropathy. Ann Med Interne 1999; 150: 117-26.
6. Vleming LJ, de Fijter JW, Westendorp RG, Daha MR, Bruijn JA, van Es LA. Histomorphometric correlates of renal failure in IgA nephropathy. Clinical Nephrol 1998; 49: 337-44.
7. D'Amico G, Colasanti G, Barbiano di Belgioioso G, Fellin G, Ragni A, Egidi F, Radaelli L, Fogazzi G, Ponticelli C, Minetti L. Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients. Semin Nephrol 1987; 4: 355-8.
8. Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 2000; 57: 1818-35.
9. Frimat L, Kessler M. Controversies concerning the importance of genetic polymorphism in IgA nephropathy. Nephrol Dial Transplant 2002; 17: 542-5.
10. Suzuki S, Suzuki Y, Kobayashi Y, Harada T, Kawamura T, Yoshida H, Tomino Y. Insertion/deletion polymorphism in ACE gene is not associated with renal progression in Japanese patients with IgA nephropathy. Am J Kidney Dis 2000; 35: 896-903.
11. Goto S, Narita I, Saito N, Watanabe Y, Yamazaki H, Sakatsume M, Shimada H, Nishi S, Ueno M, Akazawa K, Arakawa M, Gejyo F. A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy. Kidney Int 2002; 62: 980-5.
12. Carey RM. Update on the role of the AT2 receptor. Curr Opin Nephrol Hypertens 2005; 14: 67-71.
13. Chan LY, Leung JC, Tang SC, Choy CB, Lai KN. Tubular Expression of Angiotensin II Receptors and Their Regulation in IgA Nephropathy. J Am Soc Nephrol 2005; 16: 2306-17.
14. Pettersson-Fernholm K, Frojdo S, Fagerudd J, Thomas MC, Forsblom C, Wessman M, Groop PH, FinnDiane Study Group. The AT2 gene may have a gender-specific effect on kidney function and pulse pressure in type 1 diabetic patients. Kidney Int 2006; 69: 1880-4.
15. Levey AS, Greene T, Kusek JW, Beck GJ, Group MS. A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 2000; 11: A0828.
16. Hiraoka M, Taniguchi T, Nakai H, Kino M, Okada Y, Tanizawa A, Tsukahara H, Ohshima Y, Muramatsu I, Mayumi M. No evidence for AT2R gene derangement in human urinary tract abnormalies. Kidney Int 2001; 59: 1244-9.
17. Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy. Semin Nephrol 2004; 24: 197-217.
18. Nishimura H, Yerkes E, Hohenfellner K, Miyazaki Y, Ma J, Hunley TE, Yoshida H, Ichiki T, Threadgill D, Phillips JA 3rd, Hogan BM, Fogo A, Brock JW 3rd, Inagami T, Ichikawa I. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 1999; 3: 1-10.
19. Falcon BL, Stewart JM, Bourassa E, Katovich MJ, Walter G, Speth RC, Sumners C, Raizada MK. Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension. Physiol Genomics 2004; 19: 255-61.
20. Kotani K, Sakane N, Saiga K, Tsuzaki K, Sano Y, Mu H, Kurozawa Y. The angiotensin II type 2 receptor gene polymorphism and body mass index in healthy Japanese women. Ann Clin Biochem 2007; 44: 83-5.
21. Jones A, Dhamrait SS, Payne JR, Hawe E, Li P, Toor IS, Luong L, Wootton PT, Miller GJ, Humphries SE, Montgomery HE. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension 2003; 42: 500-6.
22. Jin JJ, Nakura J, Wu Z, Yamamoto M, Abe M, Chen Y, Tabara Y, Yamamoto Y, Igase M, Bo X, Kohara K, Miki T. Association of angiotensin II type 2 receptor gene variant with hypertension. Hypertens Res 2003; 26: 547-52.
23. Miyaki K, Hara A, Araki J, Zhang L, Song Y, Kimura T, Omae K, Muramatsu M. C3123A polymorphism of the angiotensin II type 2 receptor gene and salt sensitivity in healthy Japanese men. J Hum Hypertens 2006; 20: 467-9.
24. Schmieder RE, Erdmann J, Delles C, Jacobi J, Fleck E, Hilgers K, Regitz-Zagrosek V. Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans. J Am Coll Cardiol 2001; 37: 175-82.